These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30156993)

  • 1. Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.
    Pearson JA; Agriantonis A; Wong FS; Wen L
    Hum Vaccin Immunother; 2018; 14(11):2580-2596. PubMed ID: 30156993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host gene effects on gut microbiota in type 1 diabetes.
    Guo K; Huang J; Zhou Z
    Biochem Soc Trans; 2022 Jun; 50(3):1133-1142. PubMed ID: 35521897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis.
    Dedrick S; Sundaresh B; Huang Q; Brady C; Yoo T; Cronin C; Rudnicki C; Flood M; Momeni B; Ludvigsson J; Altindis E
    Front Endocrinol (Lausanne); 2020; 11():78. PubMed ID: 32174888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of Type 1 Diabetes and Gut Microbiota Role.
    Del Chierico F; Rapini N; Deodati A; Matteoli MC; Cianfarani S; Putignani L
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome in type 1 diabetes: the immunological perspective.
    Rampanelli E; Nieuwdorp M
    Expert Rev Clin Immunol; 2023 Jan; 19(1):93-109. PubMed ID: 36401835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota and Type 1 Diabetes.
    Gülden E; Wong FS; Wen L
    Clin Immunol; 2015 Aug; 159(2):143-53. PubMed ID: 26051037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 Deficiency Accelerates Type 1 Diabetes Development
    Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
    Front Immunol; 2021; 12():702955. PubMed ID: 34394099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.
    Gülden E; Chao C; Tai N; Pearson JA; Peng J; Majewska-Szczepanik M; Zhou Z; Wong FS; Wen L
    J Autoimmun; 2018 Sep; 93():57-65. PubMed ID: 29960834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
    Wen L; Ley RE; Volchkov PY; Stranges PB; Avanesyan L; Stonebraker AC; Hu C; Wong FS; Szot GL; Bluestone JA; Gordon JI; Chervonsky AV
    Nature; 2008 Oct; 455(7216):1109-13. PubMed ID: 18806780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia.
    Rouland M; Beaudoin L; Rouxel O; Bertrand L; Cagninacci L; Saffarian A; Pedron T; Gueddouri D; Guilmeau S; Burnol AF; Rachdi L; Tazi A; Mouriès J; Rescigno M; Vergnolle N; Sansonetti P; Christine Rogner U; Lehuen A
    Gut; 2022 Feb; 71(2):296-308. PubMed ID: 33593807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
    Simmons KM; Gottlieb PA; Michels AW
    Curr Diab Rep; 2016 Oct; 16(10):97. PubMed ID: 27558810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.
    Majumdar S; Lin Y; Bettini ML
    Front Immunol; 2022; 13():974178. PubMed ID: 36059452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives.
    Mishra SP; Wang S; Nagpal R; Miller B; Singh R; Taraphder S; Yadav H
    Microorganisms; 2019 Mar; 7(3):. PubMed ID: 30832381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.
    Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L
    Front Immunol; 2019; 10():2654. PubMed ID: 31798584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota derived factors as drivers of type 1 diabetes.
    Tillett BJ; Hamilton-Williams EE
    Prog Mol Biol Transl Sci; 2020; 171():215-235. PubMed ID: 32475523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum Vitamin D Concentrations, Induced
    Martens PJ; Centelles-Lodeiro J; Ellis D; Cook DP; Sassi G; Verlinden L; Verstuyf A; Raes J; Mathieu C; Gysemans C
    Front Immunol; 2022; 13():902678. PubMed ID: 35784365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.
    Mullaney JA; Stephens JE; Geeling BE; Hamilton-Williams EE
    Immunol Cell Biol; 2019 Jan; 97(1):97-103. PubMed ID: 30191611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.